0Y71

MALIN CORPORATION PLC MALIN CORPORATION ORD SHS

TitleTime
Poseida Initiates Dosing in Ph 1 PSMAThu 21/05/20 | 07:00
Block listing Interim ReviewTue 05/05/20 | 07:00
Director/PDMR ShareholdingTue 07/04/20 | 07:00
Director/PDMR ShareholdingFri 27/03/20 | 07:00
Directorate ChangeWed 25/03/20 | 07:01
Malin Announces 2019 Full Year ResultsWed 25/03/20 | 07:00
Notice of ResultsThu 05/03/20 | 07:00
Holding(s) in CompanyWed 11/12/19 | 17:31
Holding(s) in CompanyWed 11/12/19 | 11:17
Sale of 3D4Medical LimitedWed 27/11/19 | 07:05
Holding(s) in CompanyThu 14/11/19 | 16:48
Mycovia early completion of Phase 3 enrolmentWed 13/11/19 | 07:00
Block listing Interim ReviewMon 04/11/19 | 07:00
Mycovia announces partnerships for VT-1161Tue 29/10/19 | 07:18
Change of Registered OfficeThu 17/10/19 | 07:00
Confirmation of Pentwater's 26% interest inTue 08/10/19 | 07:00
Holding(s) in CompanyThu 03/10/19 | 17:30
Holding(s) in CompanyTue 01/10/19 | 07:00
Holding(s) in CompanyThu 26/09/19 | 16:45
Holding(s) in CompanyThu 26/09/19 | 16:45
Holding(s) in CompanyThu 26/09/19 | 16:45
Director/PDMR ShareholdingFri 20/09/19 | 17:10
Malin announces 2019 Interim ResultsTue 03/09/19 | 07:00
Notice of 2019 interim resultsFri 09/08/19 | 07:00
Directorate ChangeFri 02/08/19 | 17:00
Kymab and LifeArc announce strategic partnershipMon 24/06/19 | 12:23
Appointment of Liberum as Joint Corporate BrokerWed 05/06/19 | 07:00
PDMR HoldingTue 28/05/19 | 07:00
Poseida's P-BCMA-101 receives Orphan DesignationTue 14/05/19 | 07:00
Kymab Rule 135 Press ReleaseMon 13/05/19 | 12:42
Results of AGMThu 09/05/19 | 15:30
Board UpdateThu 09/05/19 | 11:44
Block listing Interim ReviewTue 07/05/19 | 07:00
Poseida raises $142 million in Series C FinancingTue 23/04/19 | 07:00
Holding(s) in CompanyThu 11/04/19 | 17:30
Kymab appoints Chief Executive OfficerMon 08/04/19 | 12:25
Notice of AGMMon 08/04/19 | 07:00
Full Year 2018 ResultsTue 02/04/19 | 07:00
Notice of Results & Publication of Annual ReportWed 13/03/19 | 07:00
Altan files New Drug Application with US FDAThu 07/02/19 | 12:23
Immunocore names Head of R&DWed 16/01/19 | 07:00
Poseida files for potential IPOMon 07/01/19 | 07:00
Immunocore appoints Chief Executive OfficerMon 07/01/19 | 07:00
Director/PDMR ShareholdingThu 20/12/18 | 07:00